Boothwyn Pharmacy LLC recalls Semaglutide and 1 more
- Published
- 10 Sept 2025
- Units affected
- 4 products
- Agency
- FDA
- Country
- United States
The hazard
Subpotent Drug
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy
Fluorescein 2% Ophth, 3 ML, Boothwyn Pharmacy, 800-476-7496
Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy
- Brand / company
- Boothwyn Pharmacy LLC
- Codes / lots
- 03202025@9 BUD 07/18/2025 | 06092025@23 BUD 09/09/2025 | 03202025@5, 03202025@6, 03202025@7, 03202025@8 BUD 07/18/2025 | 03202025@2, 03202025@3 and 03202025@4 BUD 07/18/2025
- Distribution
- U.S. Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 10 Sept 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.